|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.55%
|
US
|
NASDAQ
|
|
NVAX
|
Novavax, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.50%
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.47%
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
0.47%
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
0.44%
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
0.43%
|
US
|
NASDAQ
|
|
BLTE
|
Belite Bio, Inc.
|
0.43%
|
US
|
NASDAQ
|
|
ALT
|
Altimmune, Inc.
|
0.42%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.41%
|
US
|
NASDAQ
|
|
EBS
|
Emergent Biosolutions, Inc.
|
0.41%
|
US
|
NYSE
|
|
ANAB
|
AnaptysBio, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
VKTX
|
Viking Therapeutics, Inc.
|
0.39%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.39%
|
US
|
NASDAQ
|
|
BTAI
|
BioXcel Therapeutics, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
AVTE
|
Aerovate Therapeutics, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
EWTX
|
Edgewise Therapeutics, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.35%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.35%
|
US
|
NASDAQ
|